Prostate stem cells: an update.
- Author:
Guang-Wei HAN
;
Shan-Hong YI
- Publication Type:Journal Article
- MeSH:
Antigens, CD;
Biomarkers;
Cell Differentiation;
Humans;
Integrin alpha2beta1;
Male;
Prostate;
cytology;
Stem Cells;
chemistry;
cytology;
Vascular Endothelial Growth Factor A
- From:
National Journal of Andrology
2014;20(5):460-463
- CountryChina
- Language:Chinese
-
Abstract:
Stem cells are characterized by self-renewing, multipotent differentiation, and high proliferation and receiving more and more attention for their roles in the development and management of various diseases. There are epithelial stem cells and mesenchymal stem cells in the prostate. The markers of the epithelial stem cells include cytokeratin, stem cell antigen-1, and integrins alpha2beta1, CD49f, CD133, CD117, and CD44. The markers of the mesenchymal stem cells include CD30, CD44, CD133, neuron-specific enolase, and vascular endothelial growth factor receptor-1. Prostate stem cells are involved in the development and treatment of prostatic diseases. This review focuses on the latest progress in the studies of prostate stem cells.
